Pirfenidone	NNP	Pirfenidone NNP PennPOS
exerts	VBZ	exert VBZ PennPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
effects	NNS	effect NNS PennPOS
through	IN	through IN PennPOS
inhibition	NN	inhibition NN PennPOS
of	IN	of pp-f NUPOS
GLI	NNP	gli NN PennPOS
transcription	NN	transcription NN PennPOS
factors	NNS	factor NNS PennPOS
.	.	. . NUPOS

Pirfenidone	NNP	Pirfenidone NNP PennPOS
is	VBZ	be vbz NUPOS
an	DT	a dt NUPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
drug	NN	drug NN PennPOS
,	,	, , NUPOS
recently	RB	recent av-j NUPOS
approved	VBN	approve vvn NUPOS
for	IN	for c-acp NUPOS
the	DT	the dt NUPOS
treatment	NN	treatment NN PennPOS
of	IN	of pp-f NUPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
.	.	. . NUPOS

Although	IN	although cs NUPOS
pirfenidone	NN	pirfenidone NN PennPOS
exhibits	VBZ	exhibit VBZ PennPOS
anti-inflammatory	JJ	anti-inflammatory JJ PennPOS
,	,	, , NUPOS
antioxidant	JJ	antioxidant JJ PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
properties	NNS	property NNS PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
molecular	JJ	molecular JJ PennPOS
mechanism	NN	mechanism NN PennPOS
underlying	VBG	underlie VBG PennPOS
its	PRP$	its po31 NUPOS
protective	JJ	protective JJ PennPOS
effects	NNS	effect NNS PennPOS
remains	VBZ	remain VBZ PennPOS
unknown	JJ	unknown JJ PennPOS
.	.	. . NUPOS

Here	RB	here av NUPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
link	VBP	link VBP PennPOS
pirfenidone	NN	pirfenidone NN PennPOS
action	NN	action NN PennPOS
with	IN	with pp NUPOS
the	DT	the dt NUPOS
regulation	NN	regulation NN PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
profibrotic	JJ	profibrotic JJ PennPOS
hedgehog	NN	hedgehog NN PennPOS
(	(	( ( NUPOS
Hh	NN	hh NN PennPOS
)	)	) ) NUPOS
signaling	NN	signaling NN PennPOS
pathway	NN	pathway NN PennPOS
.	.	. . NUPOS

We	PRP	we pns12 NUPOS
demonstrate	VBP	demonstrate VBP PennPOS
that	IN	that cst NUPOS
pirfenidone	NN	pirfenidone NN PennPOS
selectively	RB	selective RB PennPOS
destabilizes	VBZ	destabilize VBZ PennPOS
the	DT	the dt NUPOS
glioma-associated	JJ	glioma-associated JJ PennPOS
oncogene	NN	oncogene NN PennPOS
homolog	NN	homolog NN PennPOS
(	(	( ( NUPOS
GLI	NN	gli NN PennPOS
)	)	) ) NUPOS
2	CD	2 crd NUPOS
protein	NN	protein NN PennPOS
,	,	, , NUPOS
the	DT	the dt NUPOS
primary	JJ	primary JJ PennPOS
activator	NN	activator NN PennPOS
of	IN	of pp-f NUPOS
Hh-mediated	JJ	hh-mediated JJ PennPOS
gene	NN	gene NN PennPOS
transcription	NN	transcription NN PennPOS
.	.	. . NUPOS

Consequently	RB	consequent av-j NUPOS
,	,	, , NUPOS
pirfenidone	NN	pirfenidone NN PennPOS
decreases	VBZ	decrease VBZ PennPOS
overall	JJ	overall JJ PennPOS
Hh	NN	hh NN PennPOS
pathway	NN	pathway NN PennPOS
activity	NN	activity NN PennPOS
in	IN	in IN PennPOS
patients	NNS	patient NNS PennPOS
with	IN	with pp NUPOS
IPF	NN	IPF NN PennPOS
and	CC	and cc NUPOS
in	IN	in IN PennPOS
patient-derived	JJ	patient-derived JJ PennPOS
primary	JJ	primary JJ PennPOS
lung	NN	lung NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
and	CC	and cc NUPOS
leads	VBZ	lead VBZ PennPOS
to	TO	to p-acp NUPOS
diminished	VBN	diminish VBN PennPOS
levels	NNS	level NNS PennPOS
of	IN	of pp-f NUPOS
Hh	NN	hh NN PennPOS
target	NN	target NN PennPOS
genes	NNS	gene NNS PennPOS
,	,	, , NUPOS
such	JJ	such JJ PennPOS
as	IN	as c-acp NUPOS
GLI1	NN	GLI1 NN PennPOS
,	,	, , NUPOS
Hh	NN	hh NN PennPOS
receptor	NN	receptor NN PennPOS
Patched-1	NN	Patched-1 NN PennPOS
,	,	, , NUPOS
a-smooth-muscle-actin	NN	a-smooth-muscle-actin NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
fibronectin	NN	fibronectin NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
to	TO	to p-acp NUPOS
reduced	VBN	reduce VBN PennPOS
cell	NN	cell NN PennPOS
migration	NN	migration NN PennPOS
and	CC	and cc NUPOS
proliferation	NN	proliferation NN PennPOS
.	.	. . NUPOS

Interestingly	RB	interesting RB PennPOS
,	,	, , NUPOS
Hh-triggered	JJ	hh-triggered JJ PennPOS
TGF-b1	NN	TGF-b1 NN PennPOS
expression	NN	expression NN PennPOS
potentiated	VBD	potentiate VBD PennPOS
Hh	NN	hh NN PennPOS
responsiveness	NN	responsiveness NN PennPOS
of	IN	of pp-f NUPOS
primary	JJ	primary JJ PennPOS
lung	NN	lung NN PennPOS
fibroblasts	NNS	fibroblast NNS PennPOS
by	IN	by IN PennPOS
elevating	VBG	elevate VBG PennPOS
the	DT	the dt NUPOS
available	JJ	available JJ PennPOS
pool	NN	pool NN PennPOS
of	IN	of pp-f NUPOS
glioma-associated	JJ	glioma-associated JJ PennPOS
oncogene	NN	oncogene NN PennPOS
homolog	NN	homolog NN PennPOS
(	(	( ( NUPOS
GLI	NN	gli NN PennPOS
)	)	) ) NUPOS
1/GLI2	NN	1/GLI2 NN PennPOS
,	,	, , NUPOS
thus	RB	thus av NUPOS
creating	VBG	create VBG PennPOS
a	DT	a dt NUPOS
vicious	JJ	vicious JJ PennPOS
cycle	NN	cycle NN PennPOS
of	IN	of pp-f NUPOS
amplifying	VBG	amplify VBG PennPOS
fibrotic	JJ	fibrotic JJ PennPOS
processes	NNS	process n2 NUPOS
.	.	. . NUPOS

Because	IN	because c-acp NUPOS
GLI	NNP	gli NN PennPOS
transcription	NN	transcription NN PennPOS
factors	NNS	factor NNS PennPOS
are	VBP	be vbb NUPOS
not	RB	not xx NUPOS
only	RB	only av-j NUPOS
crucial	JJ	crucial JJ PennPOS
for	IN	for c-acp NUPOS
Hh-mediated	JJ	hh-mediated JJ PennPOS
changes	NNS	change NNS PennPOS
but	CC	but cc-acp NUPOS
are	VBP	be vbb NUPOS
also	RB	also av NUPOS
required	VBN	require VBN PennPOS
as	IN	as c-acp NUPOS
mediators	NNS	mediator NNS PennPOS
of	IN	of pp-f NUPOS
TGF-b	NN	TGF-b NN PennPOS
signaling	NN	signaling NN PennPOS
,	,	, , NUPOS
our	PRP$	our po12 NUPOS
findings	NNS	finding n2 NUPOS
suggest	VBP	suggest VBP PennPOS
that	IN	that cst NUPOS
pirfenidone	NN	pirfenidone NN PennPOS
exerts	VBZ	exert VBZ PennPOS
its	PRP$	its po31 NUPOS
clinically	RB	clinical RB PennPOS
beneficial	JJ	beneficial JJ PennPOS
effects	NNS	effect NNS PennPOS
through	IN	through IN PennPOS
dual	JJ	dual JJ PennPOS
Hh/TGF-b	NN	Hh/TGF-b NN PennPOS
inhibition	NN	inhibition NN PennPOS
by	IN	by IN PennPOS
targeting	VBG	target VBG PennPOS
the	DT	the dt NUPOS
GLI2	NN	GLI2 NN PennPOS
protein.-Didiasova	NN	protein.-Didiasova NN PennPOS
,	,	, , NUPOS
M.	NNP	m. n1 NUPOS
,	,	, , NUPOS
Singh	NNP	Singh np1 NUPOS
,	,	, , NUPOS
R.	NNP	R. np1 NUPOS
,	,	, , NUPOS
Wilhelm	NNP	Wilhelm np1 NUPOS
,	,	, , NUPOS
J.	NNP	J. np1 NUPOS
,	,	, , NUPOS
Kwapiszewska	NNP	Kwapiszewska NNP PennPOS
,	,	, , NUPOS
G.	NNP	G. np1 NUPOS
,	,	, , NUPOS
Wujak	NNP	Wujak NNP PennPOS
,	,	, , NUPOS
L.	NNP	L. np1 NUPOS
,	,	, , NUPOS
Zakrzewicz	NNP	Zakrzewicz NNP PennPOS
,	,	, , NUPOS
D.	NNP	D. NNP PennPOS
,	,	, , NUPOS
Schaefer	NNP	Schaefer np1 NUPOS
,	,	, , NUPOS
L.	NNP	L. np1 NUPOS
,	,	, , NUPOS
Markart	NNP	Markart NNP PennPOS
,	,	, , NUPOS
P.	NNP	P. np1 NUPOS
,	,	, , NUPOS
Seeger	NNP	Seeger np1 NUPOS
,	,	, , NUPOS
W.	NNP	W. np1 NUPOS
,	,	, , NUPOS
Lauth	NNP	Lauth NNP PennPOS
,	,	, , NUPOS
M.	NNP	m. n1 NUPOS
,	,	, , NUPOS
Wygrecka	NNP	Wygrecka NNP PennPOS
,	,	, , NUPOS
M.	NNP	m. n1 NUPOS
Pirfenidone	NNP	Pirfenidone NNP PennPOS
exerts	VBZ	exert VBZ PennPOS
antifibrotic	JJ	antifibrotic JJ PennPOS
effects	NNS	effect NNS PennPOS
through	IN	through IN PennPOS
inhibition	NN	inhibition NN PennPOS
of	IN	of pp-f NUPOS
GLI	NNP	gli NN PennPOS
transcription	NN	transcription NN PennPOS
factors	NNS	factor NNS PennPOS
.	.	. . NUPOS

